Lysophospholipid and fatty acid inhibition of pulmonary surfactant: Non-enzymatic models of phospholipase A2 surfactant hydrolysis

Macklem, 1970, The stability of peripheral airways, Respir. Physiol., 8, 191, 10.1016/0034-5687(70)90015-0 Enhorning, 1993, Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube, J. Appl. Physiol., 74, 2922, 10.1152/jappl.1993.74.6.2922 Pattle, 1955, Properties, function and origin of the alveolar lining layer, Nature, 175, 1125, 10.1038/1751125b0 Bernhard, 2004, From birds to humans: new concepts on airways relative to alveolar surfactant, Am. J. Respir. Cell Mol. Biol., 30, 6, 10.1165/rcmb.2003-0158TR Postle, 2001, A comparison of the molecular species compositions of mammalian lung surfactant phospholipids, Comp. Biochem. Physiol., Part A: Mol. Integr. Physiol., 129, 65, 10.1016/S1095-6433(01)00306-3 Gunther, 2002, Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties, Eur. Respir. J., 19, 797, 10.1183/09031936.02.00243302 Schmidt, 2001, Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia, Am. J. Respir. Crit. Care Med., 163, 95, 10.1164/ajrccm.163.1.9903029 Poynter, 2003, Surfactant biology and clinical application, Crit. Care Clin., 19, 459, 10.1016/S0749-0704(03)00011-3 Pallua, 1997, Intrabronchial surfactant administration in inhalation trauma of severely burned patients with ARDS. Initial case reports, Unfallchirurg, 100, 363, 10.1007/s001130050131 Hohlfeld, 1999, Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge, Am. J. Respir. Crit. Care Med., 159, 1803, 10.1164/ajrccm.159.6.9806145 Jarjour, 1999, Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant, Am. J. Respir. Crit. Care Med., 160, 336, 10.1164/ajrccm.160.1.9806155 Hite, 2001, Phospholipase A2-mediated phosphatidylglycerol deficiency predicts surfactant dysfunction in asthma, Am. J. Respir. Crit. Care Med., 163, A733 Hite, 2004, Surfactant phospholipid changes after antigen challenge: a role for phosphatidylyglycerol in dysfunction, Am. J. Physiol.: Lung Cell. Mol. Physiol., 288, 610 Hallman, 1989, Composition and function of pulmonary surfactant in adult respiratory distress syndrome, Eur. Respir. J., 104s Nag, 1999, SP-B refining of pulmonary surfactant phospholipid films, Am. J. Physiol., 277, L1179 Krill, 1994, Pulmonary lung surfactant synthetic peptide concentration-dependent modulation of DPPC and POPG acyl chain order in a DPPC:POPG:palmitic acid lipid mixture, Chem. Phys. Lipids, 71, 47, 10.1016/0009-3084(94)02316-6 Hite, 1998, Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2, Am. J. Physiol., 275, L740 Hite, 2005, Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A2-mediated surfactant dysfunction, Am. J. Physiol., Lung Cell. Mol. Physiol., 288, 618, 10.1152/ajplung.00274.2004 Bezzine, 2002, On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids, J. Biol. Chem., 277, 48523, 10.1074/jbc.M203137200 Singer, 2002, Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2, J. Biol. Chem., 277, 48535, 10.1074/jbc.M205855200 Waite, 1987 Hallman, 1985, Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant, Pediatr. Res., 19, 286, 10.1203/00006450-198503000-00006 Wright, 2000, Altered airway surfactant phospholipid composition and reduced lung function in asthma, J. Appl. Physiol., 89, 1283, 10.1152/jappl.2000.89.4.1283 Evans, 2004, The calcium binding loops of the cytosolic phospholipase A2 C2 domain specify targeting to Golgi and ER in live cells, Mol. Biol. Cell, 15, 371, 10.1091/mbc.E03-05-0338 Gelb, 2000, Cloning and recombinant expression of a structurally novel human secreted phospholipase A2, J. Biol. Chem., 275, 39823, 10.1074/jbc.C000671200 Valentin, 2000, Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins, Biochim. Biophys. Acta, 1488, 59, 10.1016/S1388-1981(00)00110-4 Kramer, 1989, Structure and properties of a human non-pancreatic phospholipase A2, J. Biol. Chem., 264, 5768, 10.1016/S0021-9258(18)83616-X Franson, 1977, Phospholipase A activity associated with membranes of human polymorphonuclear leucocytes, Biochem. J., 167, 839, 10.1042/bj1670839 Degousee, 2001, Groups IV, V and X phospholipases A2 in human neutrophils. Role in eicosanoid production and gram negative bacterial phospholipid hydrolysis, J. Biol. Chem., 277, 5061, 10.1074/jbc.M109083200 Balsinde, 1988, Phospholipase A2 activity in resting and activated human neutrophils. Substrate specificity, pH dependence and subcellular localization, J. Biol. Chem., 263, 1929, 10.1016/S0021-9258(19)77967-8 Seeds, 2003, Human eosinophil group IID secretory phospholipase A2 causes surfactant dysfunction, Chest, 123, 376S, 10.1378/chest.123.3_suppl.376S Seeds, 2000, Cell-specific expression of group X and group V secretory phospholipases A(2) in human lung airway epithelial cells, Am. J. Respir. Cell Mol. Biol., 23, 37, 10.1165/ajrcmb.23.1.4034 Bowton, 1997, Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics, Am. J. Respir. Crit. Care Med., 155, 421, 10.1164/ajrccm.155.2.9032172 Chilton, 1996, Antigen-induced generation of lyso-phospholipids in human airways, J. Exp. Med., 183, 2235, 10.1084/jem.183.5.2235 Arbibe, 1998, Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction, J. Clin. Invest., 102, 1152, 10.1172/JCI3236 Hallman, 1982, Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol, J. Clin. Invest., 70, 673, 10.1172/JCI110662 Kim, 1995, Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome, Am. J. Physiol., 269, L109 Holm, 1991, Inhibition of pulmonary surfactant function by phospholipases, J. Appl. Physiol., 71, 317, 10.1152/jappl.1991.71.1.317 Enhorning, 1977, Pulsating bubble technique for evaluating pulmonary surfactant, J. Appl. Physiol., 43, 198, 10.1152/jappl.1977.43.2.198 Bartlett, 1959, Phosphorus assay in column chromatography, J. Biol. Chem., 234, 466, 10.1016/S0021-9258(18)70226-3 Bernal, 2000, Fetal surfactant as a source of arachidonate in human amniotic fluid, Prostaglandins Other Lipid Mediators, 60, 59, 10.1016/S0090-6980(99)00050-7 Holm, 1999, Multiple mechanisms of lung surfactant inhibition, Pediatr. Res., 46, 85, 10.1203/00006450-199907000-00015 Chabot, 2003, Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2, J. Immunol., 171, 995, 10.4049/jimmunol.171.2.995 Possmayer, 2001, Surface activity in vitro: role of surfactant proteins, Comp. Biochem. Physiol., A Mol. Integr. Physiol., 129, 209, 10.1016/S1095-6433(01)00317-8 Gregory, 1991, Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome, J. Clin. Invest., 88, 1976, 10.1172/JCI115523 Seidner, 1988, Lysophosphatidylcholine uptake and metabolism in the adult rabbit lung, Biochim. Biophys. Acta, Lipids Lipid Metab., 961, 328, 10.1016/0005-2760(88)90080-X Triggiani, 1997, Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo, Int. Arch. Allergy Immunol., 113, 190, 10.1159/000237543 Ackerman, 2003, Hydrolysis of surfactant phospholipids catalyzed by phospholipase A2 and eosinophil lysophospholipases causes surfactant dysfunction: a mechanism for small airway closure in asthma, Chest, 123, 355S, 10.1378/chest.123.3_suppl.355S Cockshutt, 1991, Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins, Biochim. Biophys. Acta, 1086, 63, 10.1016/0005-2760(91)90155-B